| |
|
|
|
Xtalks, Online
2024-11-18
Microneedle array patches (MAPs) are a groundbreaking technology in drug delivery, offering the potential to revolutionize how medications and vaccines are administered. MAPs could offer a more intuitive and efficient approach to drug delivery for a wide range of therapeutics. However, as with any innovative technology, the path from concept to market presents numerous challenges.
Innovators in the space need to optimize drug delivery capacity, ensure consistent performance and scale-up manufacturing processes to meet rigorous current good manufacturing practice (cGMP) standards. Overcoming these hurdles is crucial not only for realizing the full potential of intradermal technology but also for attracting the investment needed to bring these products through late-stage clinical trials to market.
This webinar will provide a comprehensive exploration of the critical characterization methods essential for advancing MAP development. The expert panel will provide an overview of microneedle types and their clinical benefits, setting the stage for an in-depth examination of characterization techniques.
Participants will be guided through a multifaceted approach to product evaluation, encompassing analytical, performance and preclinical assessments. From chemical assays and physical property analyses to sophisticated benchtop evaluations of array velocity and puncture performance, they will explore the methods required to ensure MAP efficacy and safety.
The webinar will also consider the crucial role of preclinical evaluations, highlighting techniques for assessing skin penetration and delivery efficiency that are vital for predicting clinical performance. By attending this webinar, participants will gain insights into the tools and approaches shaping the future of microneedle technology. Attendees will leave with a deeper understanding of how comprehensive characterization methods can de-risk intradermal development, potentially accelerating the path to clinical trials and commercial production.
This webinar offers a unique opportunity to stay at the forefront of this innovative field and contribute to the advancement of more accessible, patient-friendly drug delivery systems.
Register for this webinar today to gain insights into microneedle array patches and how the challenges of bringing this groundbreaking drug delivery technology to market can be overcome.
Keywords: Vaccine, Drug Development, Drug Delivery, GMP, Regulatory, Microneedle Patch, Laboratory Technology, Drug Delivery Devices, Vaccine Manufacturing
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Andrew Riso, Vice President of Dermal Delivery and Licensing, Kindeva Drug Delivery
Dr. Mahmoud Ameri, Co-Founder, Zosano Pharma
Ben Newton, R&D Engineering Manager, Kindeva Drug Delivery
Dr. Scott Burton, R&D Principal Scientist, Kindeva Drug Delivery
Vinh Hua, Lab Manager, Kindeva Drug Delivery
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-11-18
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|